250711

antibody from Abbiotec

Targeting: IGF2 C11orf43, FLJ44734, IGF-II

Western blot (Recommended by provider)

ELISA (Recommended by provider)

Immunoprecipitation (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

250711

Provider

Abbiotec

Proper citation

Abbiotec Cat#250711, RRID:AB_2122521

Product name

IGF2 Antibody

Antibody type

Polyclonal

Antigen

KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human IGF2.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Vial size

0.1 mg

Concentration

Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4 with 0.09% sodium azide. Antibody was purified by Protein-G affinity chromatography.

Storage

Store at -20°C. Minimize freeze-thaw cycles. Product is guaranteed one year from the date of shipment.

References

Submitted references

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Jan 20;30(3):256-62

---

Induction of insulin-like growth factor 2 expression in a mesenchymal cell line co-cultured with an ameloblast cell line.

Matsumoto A, Harada H, Saito M, Taniguchi A
In vitro cellular & developmental biology. Animal 2011 Oct;47(9):675-80